Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2)

AD Kaye, MR Jones, AM Kaye… - Pain …, 2017 - scholarlycommons.pacific.edu
Chronic pain and prescription opioid abuse are extremely prevalent in the United States and
worldwide. The consequences of opioid misuse can be life-threatening with significant …

Costs and consequences: a review of discharge opioid prescribing for ongoing management of acute pain

PE Macintyre, CA Huxtable, SLP Flint… - … and intensive care, 2014 - journals.sagepub.com
Over recent years there has been a growing need for patients to be sent home from hospital
with prescribed opioids for ongoing management of their acute pain. Increasingly complex …

Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin

TJ Cicero, MS Ellis - JAMA psychiatry, 2015 - jamanetwork.com
Importance In an effort to reduce wide-scale abuse of the proprietary oxycodone
hydrochloride formulation OxyContin, an abuse-deterrent formulation (ADF) was introduced …

Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records

CA Green, NA Perrin, SL Janoff… - … and drug safety, 2017 - Wiley Online Library
Purpose The purpose of this study is to assess positive predictive value (PPV), relative to
medical chart review, of International Classification of Diseases (ICD)‐9/10 diagnostic codes …

Mucoadhesive oral films: the potential for unmet needs

BMA Silva, AF Borges, C Silva, JFJ Coelho… - International journal of …, 2015 - Elsevier
Oral drug delivery is the most common route of drug administration. Nevertheless, there are
some important limitations that reinforce the need for developing new drug delivery systems …

[HTML][HTML] Pharmacovigilance signals of the opioid epidemic over 10 years: data mining methods in the analysis of pharmacovigilance datasets collecting adverse drug …

S Chiappini, R Vickers-Smith, A Guirguis, JM Corkery… - Pharmaceuticals, 2022 - mdpi.com
In the past twenty years, the consumption of opioid medications has reached significant
proportions, leading to a rise in drug misuse and abuse and increased opioid dependence …

Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment

SF Butler, EC McNaughton, RA Black - Pain Medicine, 2015 - academic.oup.com
Objective Abuse of prescription opioid pain relievers continues to be a serious public health
concern. In contrast to opioids such as oxycodone or morphine, tapentadol, a prescription …

Hot-melt extruded pharmaceutical dosage form

L Barnscheid, E Galia - US Patent 10,080,721, 2018 - Google Patents
The invention relates to a hot-melt extruded pharmaceutical dosage form with controlled
release of a pharmacologically active ingredient (A) embedded in a matrix comprising a …

Reductions in reported deaths following the introduction of extended‐release oxycodone (OxyContin) with an abuse‐deterrent formulation

NE Sessler, JM Downing, H Kale… - … and drug safety, 2014 - Wiley Online Library
Purpose Abuse of opioid analgesics for their psychoactive effects is associated with a large
number of fatalities. The effect of making opioid tablets harder to crush/dissolve on opioid …

Abuse-deterrent opioid formulations

RS Litman, OH Pagán, TJ Cicero - Anesthesiology, 2018 - pubs.asahq.org
Abuse-deterrent opioid formulations have been suggested as one way to decrease the
abuse, addiction, and overdose of orally prescribed opioids. Ten oral opioid formulations …